2m 2m 2m 2m 2m 2m 2m
CAPRICOR THERAP (CAPR)
NASDAQ
$27.50+$0.16 (+0.59%)
Price as of Jun 03, 2026 7:09 PM EDT- $1.7BMarket Cap
- 145.20%1-Year Change
- BiotechnologyIndustry
CAPRICOR THERAP (CAPR)
$27.50+$0.16 (+0.59%)
CAPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.34 | ||
Change | -$1.19 (-4.17%) | ||
Open | $28.05 | ||
High | $28.26 | ||
Low | $27.09 | ||
Previous Close | $28.53 | ||
Volume | 895,909 | ||
30-Day Average Volume | 1,039,931 | ||
1-Week Change | -6.88% | ||
1-Month Change | -11.55% | ||
1-Year Change | 145.20% | ||
3-Year Change | 500.88% | ||
5-Year Change | 588.66% | ||
Fundamentals | |||
Shares Outstanding | 57.9M | ||
Total Assets | $326.3M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$33.9M | ||
Free Cash Flow | -$34.4M | ||
EBIT | -$33.9M | ||
EBITDA | -$33.4M | ||
Net Working Capital | $249.5M | ||
EPS | -$0.59 | ||
Enterprise Value/EBITDA | -49 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -51 | ||
PEG | -11 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/05/2019 | ||
Earnings & Revenue